Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Minimally invasive prostate cancer treatment shows success in first patient

2.

Updates from the 2022 WHO classification of kidney epithelial tumors

3.

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

4.

Severe obesity associated with reduced prevalence of recommended cancer screenings

5.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot